Industry Insights

1. Doubling Up For Speed In Biomanufacturing 12/12/2025

   Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

2. Bioprocessing Year In Review: 11 Key Trends Accelerated By COVID-19 12/11/2020

   Despite the morbidity, deaths, and terrible societal disruptions associated with the COVID-19 pandemic, 2020 will have created something of a positive outcome for the bioprocessing sector.

3. Strategizing The Scale-Up Of Cell Therapy Manufacturing Capacity 4/19/2023

   Adaptimmune’s Mike Blankenstein, vice president of patient supply operations, discusses the team's manufacturing network strategy designed to evolve with them as the company grows from clinical to commercial supply needs, balancing cost and risk, while ensuring flexibility to respond to patients’ needs.

4. Peptides: Best Practices On Regulatory & Control Strategies, Analytical Methods, & More 6/18/2021

   Industry, regulatory, and academic experts recently gathered at the United States Pharmacopeial Convention’s (USP’s) annual Peptides & Oligonucleotides Workshop virtually to share best practices on chemistry, manufacturing, and controls (CMC) for peptides. This article summarizes discussion highlights.

5. Annex 1 Compliance Made Simple - Why Flow Rate Matters 3/20/2026

   Uncover how biofluorescent technology with particle concentration capability consolidates viable monitoring, total particle counting, and sample collection into a single Annex 1-compliant platform.

6. Challenges In Analytical Development And Testing For Gene Therapies 10/13/2021

   Given the rapid emergence of gene therapies based on recombinant adeno-associated virus (rAAV), there is a great need for appropriate analytical tools to support every lifecycle stage of these products. 

7. The 4 Technologies Poised To Transform The Pharmaceutical Supply Chain In 2025 And Beyond 12/2/2024

   These key technological advancements will significantly impact the pharma/biotech supply chain in 2025 and beyond. If you aren't implementing any of them yet, you may want to rethink your plans.

8. The Ins And Outs Of Modern Barrier Systems For Sterile Manufacturing 6/10/2024

   This article looks at key features of restricted access barrier systems and isolators and discusses some of their applications.

9. Breeze Through Surprise Audits — Take These 5 Actions Now 6/8/2023

   Summer is here! That means you might hear the dreaded words, “Surprise! We are coming to audit you!” Whether it’s a client, supplier, or regulatory agency calling for an audit, those words can strike fear in even the most organized companies. But not if you're prepared by taking these five action items now.

10. Advancing Biologics Development With Next-Gen Cell Line Development 11/17/2025

    Next-gen CLD utilizes transposase-mediated integration for speed and stability and employs an engineered cell line to enhance ADCC and a high-throughput assay for early glycosylation control.